Literature DB >> 12721312

Antibodies raised in animals against the Streptococcus agalactiae proteins c alpha and R4 and normal human serum antibodies target distinct epitopes.

Sylvester R Moyo1, Johan A Maeland1.   

Abstract

The targets for normal human serum antibodies that react with proteins c(alpha) and R4 isolated from group B streptococci (GBS; Streptococcus agalactiae) have been studied and compared with the targets for murine monoclonal and rabbit polyclonal antibodies raised against these proteins. The proteins were extracted by trypsin digestion and purified by precipitations and gel filtration and testing was based on enzyme immunoassays. The immune antibodies showed specificity for the corresponding protein, targeted that protein in Western blotting and recognized their targets after heat treatment (100 degrees C) of the proteins. Human antibodies in a commercial gammaglobulin preparation targeted a site(s) common to c(alpha) and R4. This target failed to bind the antibodies in Western blotting and was destroyed by heating. c(alpha)- and R4-reactive antibodies in sera from healthy pregnant women recognized the common, heat-labile determinant(s), but contained little or no antibodies against the heat-stable c(alpha)- or R4-specific determinants. These results are consistent with the notions that (i) the normal human antibodies and the immunization-induced animal antibodies targeted different sites on the c(alpha) and R4 proteins and that (ii) the natural human antibodies targeted conformational epitopes and the immune antibodies targeted linear epitopes. These findings are important for further clarification of GBS immunology and immunoprotection in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12721312     DOI: 10.1099/jmm.0.05087-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Immunological markers of the R4 protein of Streptococcus agalactiae.

Authors:  Johan A Maeland; Lars Bevanger; Randi Valsoe Lyng
Journal:  Clin Diagn Lab Immunol       Date:  2005-11

2.  Putative novel surface-exposed Streptococcus agalactiae protein frequently expressed by the group B streptococcus from Zimbabwe.

Authors:  Rooyen T Mavenyengwa; Johan A Maeland; Sylvester R Moyo
Journal:  Clin Vaccine Immunol       Date:  2009-07-08

3.  Streptococcus agalactiae alpha-like protein 1 possesses both cross-reacting and Alp1-specific epitopes.

Authors:  Augusta I Kvam; Rooyen T Mavenyengwa; Andreas Radtke; Johan A Maeland
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

4.  Novel aspects of the Z and R3 antigens of Streptococcus agalactiae revealed by immunological testing.

Authors:  Johan A Maeland; Andreas Radtke; Randi V Lyng; Rooyen T Mavenyengwa
Journal:  Clin Vaccine Immunol       Date:  2013-02-13

5.  A cytosol derived factor of Group B streptococcus prevent its invasion into human epithelial cells.

Authors:  Manju Ohri; Smriti Parashar; Venkatesh S Pai; Sujata Ghosh; Anuradha Chakraborti
Journal:  World J Microbiol Biotechnol       Date:  2018-03-08       Impact factor: 3.312

6.  Antigenic determinants of alpha-like proteins of Streptococcus agalactiae.

Authors:  Johan A Maeland; Lars Bevanger; Randi Valsoe Lyng
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

7.  A Secondary Antibody-Detecting Molecular Weight Marker with Mouse and Rabbit IgG Fc Linear Epitopes for Western Blot Analysis.

Authors:  Wen-Wei Lin; I-Ju Chen; Ta-Chun Cheng; Yi-Ching Tung; Pei-Yu Chu; Chih-Hung Chuang; Yuan-Chin Hsieh; Chien-Chiao Huang; Yeng-Tseng Wang; Chien-Han Kao; Steve R Roffler; Tian-Lu Cheng
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.